ÂÜÀòÂÒÂ×

Chris Beattie is a seasoned professional in clinical development and drug development, currently serving as the VP of Clinical Development at Isomab Ltd. With extensive experience across various organizations, Chris has held significant roles, including Executive Director of Global Drug Development at PRA Health Sciences, Development Director at MorEx Development Partners, and Director of Clinical & Regulatory at Onyvax Ltd. In addition to a robust career, Chris holds an MBA in Business from Warwick Business School (1987-1992) and a CPE in Law from Nottingham Trent University (1993-1995).